Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | T338I |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RET T338I lies within the extracellular domain of the Ret protein (UniProt.org). T338I results in increased cell proliferation, but is not transforming in cell culture (PMID: 21810974), and therefore, its effect on Ret protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
RET mutant RET T338I |
Transcript | NM_020975.6 |
gDNA | chr10:g.43106521C>T |
cDNA | c.1013C>T |
Protein | p.T338I |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406760.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406769.1 | chr10:g.43111352C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020630 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020975.6 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406744.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406763.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406772.1 | chr10:g.43111352C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406759.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
NM_001406765.1 | chr10:g.43106521C>T | c.1013C>T | p.T338I | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|